Capital Opportunities for Small Businesses - sbtdc

More documents

Recommendations

Info

C A P I T A L O P P O R T U N I T I E S F O R SMA L L B U S I N E S S E S Venture Firm Year Founded Capital Under Management Preferred Stage of Financing Preferred Size of Investment Preferred Industries Website Comments KBL Healthcare Ventures 1991 N/A Start-up, Early Stage & Emerging Growth; will consider Later Stage investments N/A Life Sciences (biopharmaceuticals, drug discovery platforms & advanced materials); Medical devices ("Within the medical device area, we seek companies addressing large, unmet medical needs with demonstrated clinical benefit"); Healthcare services; Medical information technology. Kleiner Perkins Caufield & Byers 1972 $1.5 billion Early Stage N/A Broadband Equipment & Services; Consumer Devices & Services; Enterprise Software & Service; Financial Services; Internet Infrastructure Software & Services; Medical Devices/Healthcare Services/Biotech. Kodiak Venture Partners 1999 $681 million Seed & Early Stage $100,000 to $3 million Communications/IT, Semiconductors, Software. Lilly BioVentures N/A N/A Early Stage N/A Biotechnology/Pharmaceuticals. Lovett Miller & Co., Inc. MCNC-RDI Seed Fundc/o MCNC Ventures, LLC MCNC Enterprise Fund- c/o MCNC Ventures, LLC N/A $175 million 2003 N/A 2003 N/A Early Stage, Growth Capital & Growth buyouts Seed/Start-up & Early Stage Early Stage (Will invest only alongside select, established VC firms & funds) typically invests $2 million to $10 million per company, but will consider smaller & larger investments $50,000 to $500,000 $500,000 to $2 million Technology products & services, Healthcare, Retailing, and other. Optical Network Technologies; Network Security & Encryption; Sensors & Actuators; Microelectronics & Microfabrication; Wireless Infrastructures; Related Biomedical Applications. Optical Network Technologies; Network Security & Encryption; Sensors & Actuators; Microelectronics & Microfabrication; Wireless Infrastructures; Related Biomedical Applications. Prefers to receive business plans via e- mail. Will consider pre-business plan & premanagement team opportunities. 102
PROFILES: VENTURE CAPITAL FUNDS ACTIVE IN NORTH CAROLINA (as of August 2011) Venture Firm Year Founded Capital Under Management Preferred Stage of Financing Preferred Size of Investment Preferred Industries Website Comments MPM Capital- BioVentures Funds Massey Burch Capital Corp. N/A >$2.1 billion All Stages 1994 >$250 million Early Stage/Start-up (80%), Later Stage (20%) historically $7 million to $50 million per company $500,000 to $2 million Life Sciences- primarily in biotechnology (80%), but also in medical devices (20%) & biopharmaceuticals. Information Technology, Communications/Internet Solutions, and Healthcare Services. Advertises itself to be the world's largest dedicated investor in Life Sciences. Will not consider real estate, oil & gas, environmental, entertainment, retail chains or pharmaceuticals. Mediphase Venture Partners N/A N/A Early Stage N/A Biopharmaceutical technology & Life Sciences information; occasionally other areas of life sciences/healthcare. Meritus Ventures, L.P. 2002 $36 million Expansion stage $250,000 - $2,500,000 The Fund has a broad industry focus that includes, but is not limited to, manufacturing, technology, and software. The Fund will invest in rural areas in the Appalachian regions of Ohio, West Virginia, Virginia, North Carolina, South Carolina, Georgia, Alabama, Mississippi, and the entire states of Arkansas, Kentucky and Tennessee. Mitsui & Co. Venture Partners, Inc. (MCVP) 1984 N/A Early Stage $1 million to $10 million per company Information Technology (software, communications, semiconductors, electronics, information services, others); Healthcare (medical devices (therapeutics/diagnostics), biopharmaceuticals, drug discovery, drug discovery tools, others). "We have provided significant value to our portfolio companies by leveraging our experience and business relationships to develop business opportunities for them in Japan, China, and the rest of Asia." Morgan Stanley Venture Partners 1985 >$1.1 billion Later Stage only (no start-ups) $5 million to $15 million Primarily Information Technology (enterprise software, Internet infrastructure, communications software & products, and wireless) and Healthcare (medical products/devices, biopharmaceuticals & healthcare IT). 103
Page 1 and 2:
C A P I T A L O P P O R T U N I T I
Page 3 and 4:
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52: C A P I T A L O P P O R T U N I T I
Page 63 and 64: APPENDIX A: QUICK REFERENCE TO SBA
Page 65 and 66: PROGRAM AMOUNT % GUARANTEE (MAX) US
Page 97 and 98: PROFILES: VENTURE CAPITAL FUNDS ACT
Page 101: PROFILES: VENTURE CAPITAL FUNDS ACT
Page 149: C A P I T A L O P P O R T U N I T I
show all

Capital Opportunities for Small Businesses - sbtdc

Create successful ePaper yourself

Delete template?

Save as template?